This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Ms. Roberta Duncan
Chief Strategy Officer at Arcturus Therapeutics
Speaker

Profile

Roberta Duncan is currently the Chief Strategy Officer, Arcturus Therapeutics and Vice Chair on the Board of Alliance for mRNA Medicines (AMM). Roberta has been in the biopharma industry for more than 26 years with experience from start-up and small biotech to pharma and CROs. Most recently, Roberta was Vice President leading CSL’s mRNA Program. Roberta has a proven track record, across industry-leading organizations, of leading innovative, complex programs across multiple therapeutic areas and business functions. She earned her BA in Biochemistry from New York University, as well as two MBAs in International Management and Strategy from Krannert School of Management and TiasNimbas Business School.

Agenda Sessions

  • Panel Discussion: mRNA Therapies – The Next Chapter

    4:15pm